Your browser doesn't support javascript.
loading
Imeglimin-mediated glycemic control in maternally inherited deafness and diabetes.
Ishibashi, Ryoichi; Hirayama, Kiichi; Watanabe, Suzuka; Okano, Kosuke; Kuroda, Yuta; Baba, Yusuke; Kanayama, Takuma; Ito, Chiho; Kasahara, Keisuke; Aiba, Saki; Iga, Ryo; Ohtani, Ryohei; Inaba, Yosuke; Koshizaka, Masaya; Maezawa, Yoshiro; Yokote, Koutaro.
Afiliação
  • Ishibashi R; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
  • Hirayama K; Department of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Watanabe S; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
  • Okano K; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
  • Kuroda Y; Department of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Baba Y; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
  • Kanayama T; Department of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Ito C; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
  • Kasahara K; Department of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Aiba S; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
  • Iga R; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
  • Ohtani R; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
  • Inaba Y; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
  • Koshizaka M; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
  • Maezawa Y; Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
  • Yokote K; Department of Medicine, Division of Neurology, Kimitsu Chuo Hospital, Kisarazu, Chiba, Japan.
J Diabetes Investig ; 14(12): 1419-1422, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37715448

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Surdez / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Inibidores do Transportador 2 de Sódio-Glicose Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Surdez / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Inibidores do Transportador 2 de Sódio-Glicose Idioma: En Ano de publicação: 2023 Tipo de documento: Article